Drug & Supplement Interactions

Lithium + Erdafitinib

Brand name of Erdafitinib

  • Balversa

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated November 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line No Known Interaction

We found no known interaction between Lithium and Erdafitinib in our sources.

This also applies to Balversa, a brand name of erdafitinib.

Still Worth Knowing

  • Shared side effects: Although there is no interaction, both can cause some of the same side effects. Taken together, those side effects might add up, and a new symptom can be harder to pin on one or the other.
See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking Lithium with Erdafitinib. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Lithium and Erdafitinib Interaction Check

No Known Interaction Found

We did not find a documented interaction between Erdafitinib and Lithium in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

How We Checked

Why No Interaction Is Listed for Erdafitinib

We sort drugs into categories, such as blood thinners or antibiotics, and many supplement interactions are recorded for a whole category rather than for one drug. So we checked every category Erdafitinib is in against every category Lithium has a known interaction with.

6Categories Erdafitinib Is In
  • Erdafitinib by Name Interactions recorded for Erdafitinib itself rather than for a category. No Lithium Record
  • Cytochrome P450 3A4 (Cyp3A4) Inducers Drugs that speed up the liver enzyme CYP3A4, which can lower the levels of other drugs that enzyme breaks down. No Lithium Record
  • Cytochrome P450 2C9 (Cyp2C9) Substrates Drugs the body breaks down mainly with the liver enzyme CYP2C9; when something slows or speeds up that enzyme, their levels in the blood can rise or fall. No Lithium Record
  • Cytochrome P450 3A4 (Cyp3A4) Inhibitors Drugs that slow the liver enzyme CYP3A4, which can raise the levels of other drugs that enzyme breaks down. No Lithium Record
  • Cytochrome P450 3A4 (Cyp3A4) Substrates Drugs the body breaks down mainly with the liver enzyme CYP3A4; when something slows or speeds up that enzyme, their levels in the blood can rise or fall. No Lithium Record
  • Oral Drugs Any drug taken by mouth. No Lithium Record
11Drug Categories Lithium Interacts With
Show all 11 categories

No overlap. Erdafitinib is in none of the 11 categories Lithium interacts with, so no record links the two.

Still wondering about combining Lithium and Erdafitinib? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share

Before You Combine Them

Taking Lithium and Erdafitinib Together

What to Watch For

Side Effects Lithium and Erdafitinib Have in Common

4 side effects show up for both Lithium and Erdafitinib.

  • Each has separately been linked to the effects below. Taken together, they might add up: the same side effect from two sources might be more likely or stronger. No study of the two together says by how much.
  • If one turns up, it can be harder to tell which one is behind it, so tell your pharmacist you take both.
  • 2 of them are worth acting on rather than waiting out, marked below.
  • Low sodium Worth Acting On Additional detail

    Lithium

    Orally, lithium can cause vertigo, muscle weakness, lethargy, fatigue, and a dazed feeling. These adverse effects often improve with continued use. Fine tremor can occur and may persist with continued use. Chronic use of lithium can cause mild cognitive and memory impairment, particularly in the presence of dehydration or hyponatremia (9,15,97745).

    Source: , the clinical database we license.

    6 references cited
    1. 9. Martindale W. Martindale the Extra Pharmacopoeia. Pharmaceutical Press, 1999.
    2. 15. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
    3. 97745. Foulser P, Abbasi Y, Mathilakath A, Nilforooshan R. Do not treat the numbers: lithium toxicity. BMJ Case Rep. 2017;2017. pii: bcr-2017-220079. PubMed
    4. 105344. Benjelloun R, Motaib I, Otheman Y. Lithium-associated hypercalcemia presenting with neuropsychiatric manifestations in a patient with bipolar disorder. Case Rep Psychiatry. 2020;2020:6630838. PubMed
    5. 111316. Yang Q, Cheng X, Su Z, Sun L, Li M. Electroconvulsive therapy combined with lithium developed reversible pure anomic aphasia: a case report. BMC Psychiatry 2022;22(1):663. PubMed
    6. 111318. Ono R, Nishiguchi S, Kitagawa I. Lithium intoxication-associated mild encephalitis/encephalopathy with a reversible splenial lesion: A case report. Bipolar Disord 2022;24(5):551-552. PubMed

    Erdafitinib

    Source: Erdafitinib’s

    It lists this side effect in its Adverse Reactions section.

    Read Erdafitinib’s label on DailyMed ›
  • Kidney problems Worth Acting On Additional detail

    Lithium

    Orally, lithium can cause polyuria, polydipsia, and edema (9). Chronic lithium use has been reported to cause central or nephrogenic diabetes insipidus, hypocalciuric hypercalcemia, and nephrotic syndrome. Long-term lithium use is estimated to increase the odds of chronic kidney disease (CKD) by at least 2-fold and may contribute to CKD progression.

    Source: , the clinical database we license.

    6 references cited
    1. 9. Martindale W. Martindale the Extra Pharmacopoeia. Pharmaceutical Press, 1999.
    2. 104269. Hanna RM, Hasnain H, Sangalang MD, et al. Three Patients with Lithium-Associated Hyperparathyroidism: Literature Review Regarding Medical and Surgical Management. Case Rep Nephrol Dial. 2019;9(2):108-118. PubMed
    3. 104271. Nwabufor PC, Omoniyi ON, Oyibo SO. A Case of Lithium-Associated Hypocalciuric Hypercalcemia. Cureus. 2020;12(9):e10606. PubMed
    4. 111314. Zhang P, Gandhi H, Kassis N. Lithium-induced nephropathy; One medication with multiple side effects: a case report. BMC Nephrol 2022;23(1):309. PubMed
    5. 111319. Li JJ, Tan S, Kawashita T, Tagle CA, Farmand F. Central Diabetes Insipidus in the Background of Lithium Use: Consider Central Causes Despite Nephrogenic as the Most Common. Am J Case Rep 2023;24:e939034. PubMed
    6. 111315. Kawada T. Lithium use and the risk of chronic kidney disease. Basic Clin Pharmacol Toxicol 2023;132(4):295-296. PubMed

    Erdafitinib

    Source: Erdafitinib’s

    It lists this side effect in its Adverse Reactions section.

    Read Erdafitinib’s label on DailyMed ›
  • Hair loss Additional detail

    Lithium

    Orally, lithium can cause or exacerbate skin disorders such as hair loss, acne, psoriasis, and rash (9,15,97770). A case of Stevens-Johnson syndrome is also reported in a patient with bipolar disorder who took lithium carbonate at an unknown dose for 17 days.

    Source: , the clinical database we license.

    4 references cited
    1. 9. Martindale W. Martindale the Extra Pharmacopoeia. Pharmaceutical Press, 1999.
    2. 15. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
    3. 97770. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017812s028,018421s027lbl.pdf. Accessed Nov. 21, 2018
    4. 111317. Itoh M, Fukuya Y, Endo C, et al. Lithium carbonate-induced Stevens-Johnson syndrome: the first case report. Int J Dermatol 2023;62(3):e165-e167. PubMed

    Erdafitinib

    Source: Erdafitinib’s

    It lists this side effect in its Adverse Reactions section.

    Read Erdafitinib’s label on DailyMed ›
  • Tiredness reported in 4.3% of FDA reports for Erdafitinib Additional detail

    Lithium

    Orally, prescription forms of lithium are generally well tolerated when used as prescribed. Plasma levels must be monitored to avoid toxicity. It is unclear how the lower doses of lithium found in supplements may alter the occurrence and likelihood of these adverse effects.

    Most Common Adverse Effects:

    Orally: Edema, fatigue, fine tremor, gastrointestinal symptoms, lethargy, muscle weakness, polydipsia, polyuria, ski…

    Source: , the clinical database we license.

    Erdafitinib

    Source: Erdafitinib’s

    It lists this side effect in its Adverse Reactions section. Voluntary reports to the FDA mention it too.

    Read Erdafitinib’s label on DailyMed ›

Reported for Lithium but not commonly for Erdafitinib: a severe skin reaction, blood clots, memory problems and a change in thyroid levels.

Note: Effects for Erdafitinib come from the Adverse Reactions section of its FDA label; effects for Lithium come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 1,247 voluntary FDA FAERS reports for Erdafitinib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. The two sources word some effects differently, so we match them by meaning.

If You Decide to Take Both
  • Add one new thing at a time, and note the date you started it.
  • A start date turns “I’ve been feeling off” into something a pharmacist can work with.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.
Overlapping Uses

Using Lithium for the Same Condition as Erdafitinib

Why This Matters

  • The same goal. Erdafitinib is prescribed for cancer, and Lithium has been studied for it too.
  • It might help, or it might go too far. If Lithium does work for it, the two effects might add up. That might mean better control, or it might go further than intended.
  • Tell your prescriber. A graded use is not a treatment, so do not stop or replace Erdafitinib on your own. If you take Lithium for the same reason, your prescriber may want to keep a closer eye on how Erdafitinib is working.

Erdafitinib is a prescription medicine with approved uses on its FDA label. Lithium is a supplement: here is what researchers have looked at it for, and how strong that evidence is.

From the FDA Label

Erdafitinib Is Prescribed For

Erdafitinib, sold as Balversa, treats adults with locally advanced or metastatic urothelial carcinoma (cancer of the bladder and urinary tract that has spread or can't be removed). The tumor must have susceptible FGFR3 genetic alterations, and the cancer must have progressed on or after at least one earlier systemic therapy.

Read the rest of what Erdafitinib is prescribed for

An FDA-approved test on the tumor is used to confirm the FGFR3 change before treatment starts. Balversa is not recommended for people who are eligible for PD-1 or PD-L1 inhibitor therapy and have not yet received it.

From the Natural Medicines Research Record

Lithium Has Been Studied For

Studied for cancer, with too little research to rate it yet.

See what the research shows
  • Cancer Studied, Not Established
    Read what the research shows

    Although there is interest in using oral lithium supplements for cancer, there is insufficient reliable information about the clinical effects of lithium supplements for this condition.

The grades and the research summaries are from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”.

Pharmacist Q&AYou ask. We answer.

Questions Our Pharmacists Have Answered About Lithium and Erdafitinib

Real questions from readers, each answered by a licensed pharmacist at HelloPharmacist, written by a person and not generated from a database. An answer is written for the reader who asked and their situation, so read it for what to ask your own pharmacist rather than as a plan to follow.

Each one covers Lithium or Erdafitinib, not necessarily both.

  1. The pharmacist says

    There is no documented interaction between the mushrooms in these gummies and lithium carbonate. Lithium has a narrow therapeutic window so you should inform your prescriber and pharmacist before starting the gummies and continue your routine lithium blood tests. Stay alert for signs of high lithium levels like worsening tremor, nausea, diarrhea, unusual drowsiness, or confusion and contact your doctor if these occur. Check your gummy label for any additional ingredients beyond the mushrooms themselves.

    Answered by Dr. Brian Staiger, PharmD · August 2026
  2. The pharmacist says

    Lithium has a narrow safety range, so cold medications can affect lithium levels and increase toxicity risk. Avoid NSAIDs like ibuprofen and naproxen, and use caution with dextromethorphan cough medicine, as these can raise lithium levels or cause serious side effects. Safe options for colds with lithium include acetaminophen, guaifenesin, and pseudoephedrine.

    Answered by Dr. Brian Staiger, PharmD · September 2022

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Lithium Does Interact With Other Medications

Lithium has 259 major, 256 moderate known drug interactions in our database — Erdafitinib isn’t one of them. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Lithium

Covers the 2,830 medications we’ve checked against Lithium. Pick one to open its full report.

Alternatives for the Same Use

Other Supplements for the Same Uses as Lithium, and How They Mix With Erdafitinib

Choosing a supplement while you take Erdafitinib? Pick what you use Lithium for to see other options studied for it, and whether each has a documented interaction with Erdafitinib.

What do you take Lithium for?

For Diabetes

9 of them have a documented interaction with Erdafitinib: Berberine (moderate), Black Seed (moderate), Garlic (moderate), Glucomannan (moderate), Propolis (moderate), Tinospora Cordifolia (moderate), Blond Psyllium (minor) and Milk Thistle (minor).

27 other supplements have at least some evidence of a benefit for diabetes; the 8 below come first. Lithium itself is graded for it.

For Depression

2 of them have a documented interaction with Erdafitinib: St. John's Wort (major) and Dhea (moderate).

11 other supplements have at least some evidence of a benefit for depression; the 8 below come first. Lithium itself is graded for it.

For Seborrheic Dermatitis

1 of them has a documented interaction with Erdafitinib: Licorice (moderate).

9 other supplements have at least some evidence of a benefit for seborrheic dermatitis; the 8 below come first. Lithium itself is graded for it.

For Alzheimer Disease

1 of them has a documented interaction with Erdafitinib: Vitamin E (moderate).

7 other supplements have at least some evidence of a benefit for Alzheimer disease. Lithium itself is graded for it.

  • Vitamin E Graded Moderate
  • Acetyl-l-carnitine Graded No Known Interaction
  • Alpha-gpc Graded No Known Interaction
  • Huperzine A Graded No Known Interaction
  • Idebenone Graded No Known Interaction
  • Phosphatidylserine Graded No Known Interaction
  • Saffron Graded No Known Interaction

For Headache

1 of them has a documented interaction with Erdafitinib: Butterbur (moderate).

5 other supplements have at least some evidence of a benefit for headache. Lithium itself is graded for it.

For Tardive Dyskinesia

2 of them have a documented interaction with Erdafitinib: Ginkgo (moderate) and Vitamin E (moderate).

4 other supplements have at least some evidence of a benefit for tardive dyskinesia. Lithium itself is graded for it.

The grades come from the Natural Medicines database and describe the research so far, not a recommendation, and none of these supplements replaces a prescribed medicine.

Everything Else You Take

See Every Supplement That Interacts With Erdafitinib

Take other supplements too? 174 supplements have a documented interaction with Erdafitinib, each explained on its page.

By severity: 4 major, 130 moderate and 40 minor.

The Most Serious There Right Now:

Open the Erdafitinib interaction pageEvery supplement checked against Erdafitinib, ranked by severity
One More Smart Check

Taking Lithium as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Lithium. We have broken down 330 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Erdafitinib:

Get to Know Each One

About Lithium and Erdafitinib

Supplement

About Lithium

Lithium

Lithium is a naturally occurring metal that, in prescription form (lithium carbonate or citrate), is an FDA-approved, well-proven treatment for bipolar disorder. Low-dose supplement forms like lithium orotate are sold for mood support, but there is very little reliable evidence that they work, and even small amounts of lithium can be risky for some people. Always talk to a pharmacist or doctor before taking any lithium product.

Full Lithium guide: uses, dosage, safety and every interaction

On Its Own

Lithium Safety

Safety at a Glance

How Lithium Is Rated

  • Lithium Overall

    Use caution

    Lithium has a narrow safety margin and prescription forms require blood monitoring; supplement forms are not well studied.

  • Pregnancy

    Possibly Unsafe

    When lithium carbonate and lithium citrate are used orally. Lithium can cause fetal toxicity and increases the risk for cardiac and other abnormalities, including neural tube and urethral defects.

    Read the full pregnancy detail ↓
  • Breastfeeding

    Likely Unsafe

    When used orally. Lithium is secreted into breast milk and may cause adverse effects in the nursing infant.

    Read the full breastfeeding detail ↓

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center), with the full detail in the next card.

Special Populations

Lithium in Pregnancy & Breastfeeding

Pregnancy Possibly Unsafe

When lithium carbonate and lithium citrate are used orally. Lithium can cause fetal toxicity and increases the risk for cardiac and other abnormalities, including neural tube and urethral defects. However, it does not seem to increase the risk for preterm birth or low birth rate. Some research suggests lithium might increase the risk for spontaneous abortion. Based on a meta-analysis of 2 population studies, taking lithium during pregnancy may increase the risk for spontaneous abortion when compared with the general population, but not when compared with patients with affective disorders not taking lithium during pregnancy. This suggests that it may be the presence of affective disorder itself, or the possible associated use of other teratogenic drugs or substances during pregnancy, which may increase the risk for spontaneous abortion. When the potential benefits to the mother and child outweigh the possible risk to the fetus, prescription lithium may be used with close monitoring by a healthcare professional. The safety of lithium supplements during pregnancy is unknown.

Lactation Likely Unsafe

When used orally. Lithium is secreted into breast milk and may cause adverse effects in the nursing infant. Prescription lithium may be used in circumstances when the potential maternal benefits outweigh the possible risk to the infant. The infant should be closely monitored for signs of lithium toxicity.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

Medication

About Erdafitinib

Brand name: Balversa

Erdafitinib, sold as Balversa, treats adults with locally advanced or metastatic urothelial carcinoma (cancer of the bladder and urinary tract that has spread or can't be removed). The tumor must have susceptible FGFR3 genetic alterations, and the cancer must have progressed on or after at least one earlier systemic therapy.

Erdafitinib: uses, dosage and side effects Erdafitinib: interactions with other drugs Taking more than these two? Check Lithium and Erdafitinib with everything else you take Erdafitinib NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & Lithium

Browse every other medication we’ve checked against Lithium — both the ones with a known interaction and the ones without. Select any drug for the full detail.

259Major
256Moderate
0Minor
2,314No known interaction
Major

Major: 259 interactions

Showing 60 of 259 major interactions — see all 259 on the Lithium page.

Moderate

Moderate: 256 interactions

Showing 60 of 256 moderate interactions — see all 256 on the Lithium page.

No Interaction 2,314 drugs checked — show the list
How Much People Look This Up

Where Lithium and Erdafitinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Lithium
Top 25%

#212 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Erdafitinib
Steady interest

#1,775 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Lithium and Erdafitinib Together: Common Questions

Can you take Lithium with Erdafitinib?
We do not list a known interaction between Lithium and Erdafitinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Can you take Lithium with Balversa?
Balversa is a brand name of erdafitinib, so the answer is the same as for erdafitinib. We do not list a known interaction between Lithium and Erdafitinib. Everything on this page applies to Balversa too.
Do Lithium and Erdafitinib have any of the same side effects?
Yes — our sources link each of them separately to 4 of the same effects. That is not a documented interaction, but taken together the same side effect from two sources might be more likely or stronger; no study of the two together says by how much. And if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Are Lithium and Erdafitinib used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Lithium in each. That is a conversation for your prescriber, especially if Erdafitinib is being adjusted to a target.
How was the Lithium and Erdafitinib combination checked?
Interactions in our licensed database are recorded against drug classes. Erdafitinib is filed under 6 classifications, and Lithium has documented interactions with 11 drug classes — none of Erdafitinib's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Do other supplements studied for diabetes interact with Erdafitinib?
9 of the 27 other supplements the Natural Medicines database grades as having some evidence of a benefit for diabetes have a documented interaction with Erdafitinib: Berberine (moderate), Black Seed (moderate), Garlic (moderate), Glucomannan (moderate), Propolis (moderate), Tinospora Cordifolia (moderate), Blond Psyllium (minor) and Milk Thistle (minor). A grade is the research so far, not a recommendation, and no known interaction is not proof of safety; ask your pharmacist before adding one.
Does Lithium interact with any other medications?
Yes. Lithium has 515 documented drug interactions in our database — Erdafitinib is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Erdafitinib interact with any supplements?
Yes. Erdafitinib has documented interactions with 174 supplements in our database — Lithium is not one of them. The Erdafitinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 13 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 13 references
  1. 9. Martindale W. Martindale the Extra Pharmacopoeia. Pharmaceutical Press, 1999.
  2. 15. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  3. 97745. Foulser P, Abbasi Y, Mathilakath A, Nilforooshan R. Do not treat the numbers: lithium toxicity. BMJ Case Rep. 2017;2017. pii: bcr-2017-220079. PubMed
  4. 97770. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017812s028,018421s027lbl.pdf. Accessed Nov. 21, 2018
  5. 104269. Hanna RM, Hasnain H, Sangalang MD, et al. Three Patients with Lithium-Associated Hyperparathyroidism: Literature Review Regarding Medical and Surgical Management. Case Rep Nephrol Dial. 2019;9(2):108-118. PubMed
  6. 104271. Nwabufor PC, Omoniyi ON, Oyibo SO. A Case of Lithium-Associated Hypocalciuric Hypercalcemia. Cureus. 2020;12(9):e10606. PubMed
  7. 105344. Benjelloun R, Motaib I, Otheman Y. Lithium-associated hypercalcemia presenting with neuropsychiatric manifestations in a patient with bipolar disorder. Case Rep Psychiatry. 2020;2020:6630838. PubMed
  8. 111314. Zhang P, Gandhi H, Kassis N. Lithium-induced nephropathy; One medication with multiple side effects: a case report. BMC Nephrol 2022;23(1):309. PubMed
  9. 111315. Kawada T. Lithium use and the risk of chronic kidney disease. Basic Clin Pharmacol Toxicol 2023;132(4):295-296. PubMed
  10. 111316. Yang Q, Cheng X, Su Z, Sun L, Li M. Electroconvulsive therapy combined with lithium developed reversible pure anomic aphasia: a case report. BMC Psychiatry 2022;22(1):663. PubMed
  11. 111317. Itoh M, Fukuya Y, Endo C, et al. Lithium carbonate-induced Stevens-Johnson syndrome: the first case report. Int J Dermatol 2023;62(3):e165-e167. PubMed
  12. 111318. Ono R, Nishiguchi S, Kitagawa I. Lithium intoxication-associated mild encephalitis/encephalopathy with a reversible splenial lesion: A case report. Bipolar Disord 2022;24(5):551-552. PubMed
  13. 111319. Li JJ, Tan S, Kawashita T, Tagle CA, Farmand F. Central Diabetes Insipidus in the Background of Lithium Use: Consider Central Causes Despite Nephrogenic as the Most Common. Am J Case Rep 2023;24:e939034. PubMed

All 26 references behind our Lithium records are listed in the Lithium guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 15, 2026. The Lithium and Erdafitinib records this page draws on were last updated November 10, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About Lithium and Erdafitinib?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.